Heart Disease Trial, Recruiting NCT03788512 Sponsor: Xuanwu Hospital, Beijing Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT03788512
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel) or a transient ischemic attack (TIA, sometimes called a "mini-stroke").
  • People whose stroke or TIA symptoms started less than 30 days ago.
  • People who have been found to have a buildup of fatty deposits (atherosclerosis) in the blood vessels leading to or within the brain, confirmed by an ultrasound or a type of medical scan (such as a CT scan, MRI, or a specialised X-ray of blood vessels).
  • People who also have evidence of fatty deposit buildup in the blood vessels of the heart, shown by a scan or heart test, OR who have had a procedure to open or bypass blocked heart arteries in the past.

Who may not be able to join:

  • People with a serious cancer, poor organ function, or a blood disease where their estimated life expectancy is less than 5 years.
  • People who do not wish to take part in the research.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13501390691

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
12 January 2019
Est. completion
1 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Rate of Major Adverse Cardiovascular Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov